Dr. Taylor Feehley is a published immunology researcher with experience in life science corporate development and strategy. Most recently, she served in various senior corporate strategy and development roles at Omega Therapeutics and Vedanta Biosciences. Prior to joining Vedanta, she was a Senior Research Analyst at Chardan with a specialty in genetic medicines, infectious disease, and microbiome. Her academic research explored the intestinal microbiome and its role in regulating sensitization to food allergens, for which she was named to the Forbes “30 Under 30” list for Science in 2016. Taylor received a B.A. and Ph.D. from the University of Chicago and was a postdoctoral fellow at Washington University in St. Louis.